Introduction
Major depressive disorder (MDD) is a frequent disease in the general population (16.2% lifetime) with a serious socio-economic burden for society [1, 2] . Its prevalence is higher in women during the childbearing years [3] and particularly during the postnatal period with an estimated range from 7.5% to 33.1% [4] [5] [6] [7] [8] [9] [10] and a risk of recurrence of 25% [11] . Because of its adverse outcomes on maternalinfant interactions, attachment disorders and child development [12] [13] [14] [15] [16] , these depressive disorders occurring during post partum (Postpartum major depression (PPMD)) represents a major mental health problem.
A lot of data about MDD show that sleep is disturbed before [17] , during [18] and often after an acute episode [19] . In the MDD period, a specific sleep pattern of abnormalities has been very well-known for many years. There is a reduction in REM latency and slow-wave sleep time as well as an increase in sleep latency, wakefulness and sleep fragmentation [20] . These sleep specificities are still currently explored after mood normalization [19] . The exact link sleep abnormalities and mood disorders remains however to be specified. Some recent findings tend to indicate that perturbations of sleep, insomnia in particular, could be a risk factor of MDD [17] emergence and MDD relapse. Also patients with mood disorders could share a pattern of vulnerability to mood and sleep disturbances [21] and the genetic factors that could be responsible for this association are currently under study [21, 22] .
Sleep disturbances had also been consistently reported during pregnancy [23] [24] [25] such as variations in sleep duration and sleepiness, increase in nocturnal awakenings [26] , snoring [27] and restless legs syndrome [25] , and increase, decrease or stabilization in apnea and hyponea [23] . Hormonal modifications during gestation, the mechanical effects of an enlarged uterus, backache and fetal movement are involved in these sleep changes [23] . Several studies have also reported sleep deprivation during pregnancy and its negative maternal and fetal outcomes [28] . These disturbances in sleep characteristics progressively increase during pregnancy [23] [24] [25] .
However, if sleep seems to be disturbed in both pregnancy and MDD, few data are available on the sleep pattern of MDD during pregnancy and the postpartum period [29] .
Karacan et al. [30] and Coble et al. [26] reported sleep recording abnormalities in depressed pregnant women and especially decreased REM sleep. In 2007, Field et al. [31] described greater sleep alterations during pregnancy in depressed women by visual analogue scales. Goyal et al. [32] , in 124 primiparas, presented an association between higher depressive symptoms and difficulty in falling asleep, more daytime sleepiness and early awakening. In 2011, Okun et al. [33] , using a questionnaire, found in depressed pregnant women more fragmented sleep with longer sleep latencies, longer periods of nocturnal wakefulness and poorer sleep efficiency during the second half of pregnancy, and sleep deprivation at 20 weeks of gestation. The sleep pattern of pregnant women with a vulnerability of mood disorder (i.e. a history of MDD or PPMD) has also not been clearly described because only a few studies have explored this topic. A 1994 study by Coble et al. [26] comparing the EEG sleep of women with and without a history of depression, reported an increased time in bed and sleep time in early pregnancy, increased wakefulness in late pregnancy and more sleep disturbances in women with a history of MDD. In 2007, Jomeen et al. [34] found that high scores at the Pittsburg Sleep Quality Inventory (PSQI) in late pregnancy were associated with an increase of depressive symptoms in the postpartum period. However, Okun et al. [35] did not confirm this result in women at risk of depression. In 2003, Wolfson et al. [36] reported with sleep diaries in thirty-eight first-time mothers, more total sleep time, later rising times and more time napping at the end of pregnancy in women with higher depressive symptoms in postpartum. Some polysomnography data have, in high-risk women, shown different sleep abnormalities linked to postpartum depression and in particular, modifications in REM sleep [26, 37] .
Taken together these previous studies showed that the links are strength between sleep alterations during pregnancy and depressive symptoms and vulnerability. Many questions persist, however, about the links between sleep disturbances and mood during the pre and post-natal periods: Are sleep abnormalities during pregnancy associated with depressive symptoms in postpartum? Do women with a vulnerability to MDD or PPMD have a specific sleep pattern during pregnancy? And, could we characterize among vulnerable women to MDD sleep abnormalities during pregnancy associated with an increased risk of postpartum depression?
In this study, we hypothesized that high-risk depressed women (called hereafter MDD group) have greater sleep disturbances in pregnancy than non-depressed women and that sleep abnormalities during pregnancy could represent a specific marker for postpartum depression.
Materials and Methods

Participants
From September 2009 to September 2011, we recruited in the AuBE cohort (Autonomic Baby Evaluation) 302 women whose infants were born in the maternity ward of Saint-Etienne (France) [38] . This cohort was constituted to study the maturation of autonomic nervous system and sleep in children between 0 and 24 months and the relationship between maternal mood and sleep during pregnancy and postpartum. We included all consenting mothers in the study whose children met the inclusion criteria and had no exclusion criteria. Inclusion criteria at birth were: term or preterm infants with a postnatal corrected age of 37 weeks and signed parental consent. Exclusion criteria were: preterm infants with a postnatal corrected age inferior to 37 weeks, familial dysautonomy, Riley-Day syndrome, Allgrove syndrome, congenital central hypoventilation syndrome, congenital heart malformation, congenital brain stem abnormalities, Pierre Robin syndrome, disorder of cardiac rhythm, cardiac and pulmonary medication and all medications with an action on the autonomic nervous system, general analgesia in the two weeks before the inclusion. At 24 months of follow-up, 85 mothers had decided to stop the study and only 217 mothers remained in the cohort and constituted the final sample of the current study.
Procedures
Diagnosis of maternal depression: All the mothers included in this study filled in the HAD (Hospital Anxiety Depression scale) [39] to assess their depression and anxiety symptoms at 0,6,12,18 and 24 months after delivery [40] . The HAD is a self-administered questionnaire with 14 items designed to screen the anxiety and depression by eliminating somatic symptoms may distort evaluations. They also filled in a questionnaire about their history of MDD. The mothers with a HAD depression score > 8 at any time or with a positive personal history of MDD were contacted by phone for a semi-structured interview using the Mini Instrumental Mental Interview (MINI) [41] to confirm the diagnosis of MDD (in the past or after the postpartum period) or the diagnosis of PPMD according to DSM-IV criteria. We used a broad definition of PPMD limited to the 12 months after delivery. Mothers were separated into two groups: MDD and control women. Within the MDD group, two subgroups were constituted and separately analyzed: the MDOPP (women with major depression outside of the post-partum period) and PPMD (women with major depression within the post-partum period). A mean HAD depression score and a mean HAD anxiety score were also assessed to determine the level of each mother's depression and anxiety symptoms during the postpartum period (between birth and 12 months).
Evaluation of mothers' sleep during pregnancy:
On inclusion, mothers completed a form about their sleep before and in the first, second and third trimesters of pregnancy. This form had questions on total sleep time, nightmares, snoring, the need for naps, sleepiness and sleep disorders such as obstructive sleep apnea syndrome, restless legs syndrome or insomnia and their management. We collected medical and demographic data about the mother health, pregnancy and conditions of childbirth that could be linked to sleep alterations during pregnancy. These data included weight before and at the end of pregnancy, height, tobacco and coffee consumption, marital and socioeconomic status, means of her baby delivery and the term at birth.
Statistical analysis
Statistical analysis was performed using SPSS 16.0. Student's t-test was done to compare the two groups (MDD and control; and MDOPP and PPMD). A χ2 test or Fisher's exact test was used if the number of subjects was fewer than five. An analysis of correlation with Pearson's coefficient was used to examine the links between depressive symptoms and sleep duration. A multivariate analysis determined for each sleep disturbance during pregnancy if it was linked to maternal postpartum depression or to MDD in another period or to both. Logistic regressions were conducted to calculate odds ratios (ORs) with 95% confidence intervals (ICs) to illustrate the strength and significance of associations.
Results
Demographic and clinical features of mothers
Of the 217 mothers participating in the study, 45 (20.7%) smoked, 0 (0%) consumed alcohol, 119 (55%) drank coffee, 188 (86.6%) took one or more medications during pregnancy and 5 (2.3%) had antidepressant medication. They were 30.9 (± 4.5) years old, had 2 (± 1.3) gestations, a body mass index (BMI) before pregnancy of 23.1 (± 3.2) kg/m 2 and a weight gain during pregnancy of 12.2 (± 4.9) kg. On delivery, 48 (22.1%) had cesareans and 65 (29.9%) had premature rupture of membranes. Of the infants, there were 121 (55.8%) males, 8 (3.7%) twins and 11 (5%) preterm with gestational age of 34.3 (± 3.7) weeks. For the cohort, the weight at birth was of 3142.8 (± 562.9) g and the Apgar score at 5 min of 9.8 (± 0.9).
Maternal MDD
The self-administering questionnaires screened 50 mothers with a positive history of MDD or with HAD depressive symptoms > 8 at one point of evaluation. The semi-structured interview using the MINI confirmed 34 mothers (15.7%) with a diagnosis of MDD (MDD group) composed of 17 mothers (7.8%) with a diagnosis of major depression outside of the postpartum period (MDOPP) and 17 mothers (7.8%) with a postpartum depression occurring during the study (PPMD). Among the PPMD mothers, 6 had one or more past MDD. The 183 mothers (84.3%) remaining women constituted the control group.
The mean HAD depression score was significantly higher in the MDD than in the control group (t = -7.12, P < 0.001) with a maximum score for the PPMD group of 7.0 ± 2.3 compared to the MDOPP group (4.3 ± 1.9), P < 0.001. The mean HAD anxiety score was also significantly higher in the MDD than in the control group (P < 0.001) but did not differ between the PPMD and MDOPP (P > 0.05). The only significant differences in clinical or demographic data between the MDD and control groups concerned the coffee consumption that was greater in MDD than in controls (P = 0.019) and the greater number of employed women in the control than in the MDD group (P = 0.020) ( Table 1) . Apgar score at 5 minᵇ 9.8 ± 0.7 9.6 ± 1.7
Mean HAD depression scoreᵇ 
Sleep pattern during pregnancy
Of the 217 pregnant women, 60 (27.7%) had nightmares, 85 (39.2%) had pain during sleep and 63 (29.0%) snored with a significant increase of symptoms from the first to the third trimester of pregnancy. We observed that 166 (76.5%) needed naps, 150 (69.1%) had daytime sleepiness and 101 (46.5%) had morning sleepiness with a significant reduction in symptoms during the second trimester and a maximum in the last trimester. 2.3% had answered to present clinical signs of obstructive sleep apnea syndrome and 31.3% of restless legs syndrome.
Nine percent complained from insomnia, 46.2% from difficulties in falling asleep, 74.2% nocturnal awakening and 42.4% from early morning awakening.
More interesting, our results showed a significant increase in the frequency of these sleep disorders during pregnancy with a maximum of symptoms during the third trimester (Figure 1 ). The mean sleep duration per night before pregnancy was 7.7 (± 1.1) hours with an increase in the first trimester and a decrease over time: 8.0 (± 1.4) hours in the first trimester, 7.7 (± 1.4) hours in the second trimester and 7.2 (± 2.0) hours in the third trimester of pregnancy (Figure 2 ). Eleven percent of the mothers were sleep deprived (less than 7 hours per night) in the first trimester, 20.6% in the second trimester and 40.5% in the third trimester of gestation. We found no association between sleep deprivation throughout pregnancy and preterm birth, occurrence of preeclampsia, gestational diabetes or cesarean sections.
Sleep pattern during pregnancy and postpartum depressive symptoms in women
We used the mean HAD depression score to determine the links between postpartum depressive symptoms and sleep particularities during pregnancy for our entire cohort. We found significantly more = 0.014). Shorter sleep duration in the second (r = -0.255; P = 0.001) and third trimesters (r = -0.152; P = 0.049), and sleep deprivation (less than 7 hours per night) during pregnancy are also associated with higher mean HAD depression scores ( Figure 3 ).
Sleep pattern during pregnancy and maternal MDD
We first compared the sleep patterns of pregnant women with past or postpartum episodes of MDD and controls (Table 2) . MDD mothers had a shorter sleep duration during the second trimester of pregnancy (t = 2.54; P = 0.012) with sleep deprivation (fewer than 7 hours per night) in the first trimester (P = 0.048), more nocturnal awakening in the first trimester (χ 2 = 5.35; P = 0.021), more early morning awakening in the second (P = 0.038) and third trimesters (χ 2 = 6.24; P = 0.013), more pain during the sleep in the second trimester (P = 0.025) and more morning sleepiness in the first (χ 2 = 4.06; P = 0.044) and second trimesters of pregnancy (P = 0.034). They also had more nightmares (χ 2 = 4.19; P = 0.041) and more difficulties in falling asleep (χ 2 = 4.73; P = 0.030) than control women. Moreover, multivariate analysis revealed an increased probability to develop PPMD if the women had nocturnal awakening in the first trimester (P = 0.036), early morning awakening (P = 0.027), pain during sleep (P = 0.016) and morning sleepiness in the second trimester (P = 0.031). Interestingly, reported sleep disturbances were not significantly associated with MDD outside postpartum but were significantly associated with PPMD (Table 3) .
Discussion
This study compared sleep patterns of pregnant women with or without an history of depression by using, for the first time to our knowledge, depression diagnosis according to DSM-IV criteria both and explore specific sleep anomalies linked to PPMD.
First of all, the sleep alterations and their aggravation during pregnancy observed in our cohort are in accordance with previous findings in the literature [23] [24] [25] . Restless legs syndrome, nocturnal awakenings and snoring were multiplied respectively 4, 11 and 8-fold between the period prior to pregnancy and the third trimester [23] . As in Hedman et al. [23] , our findings showed that sleep duration began to decrease significantly from the second trimester of pregnancy and not later. They also revealed that apnea did not constitute a problem before and throughout the pregnancy probably because of the low percentage of obese women in our cohort. Finally, as Guilleminault et al. [42] reported in 2000, daytime sleepiness increased during the first trimester but contrary to these authors, it decreased during the second trimester in our study.
Secondly, some sleep alterations that women have during pregnancy can be associated with postpartum depressive symptoms. Like Chang et al. [28] , we observed a relationship between a reduction in the duration of sleep throughout the pregnancy and an increase depressive symptoms in the mothers with nocturnal awakening in the first (t = -2.042; P = 0.048) and second trimesters (t = -3.352; P = 0.001), early morning awakening in the second (t = -2.355; P = 0.027) and the third trimesters (t = -2.168; P = 0.032) and pain during sleep (t = -2.975; P = 0.003) in the second trimester of pregnancy. A significant increase in postpartum depressive symptoms is also linked to snoring (t = -2.206; P = 0.029) and apnea (t = -2.428; P = 0.016) in the third trimester of gestation, daytime sleepiness in the second (t = -3.747; P = 0.000) and the third trimesters (t = -1.968; P = 0.050) and morning sleepiness in the first (t = -2.329; P = 0.021), second (t = -3.855; P = 0.000) and third trimesters of pregnancy (t = -2.474; P ᵇData are presented as mean ± SD * P < 0.05 significantly different from the control group Table 3 : Impact of MDD outside pregnancy and PPMD in the "MDD group" sleep disturbances. in postpartum depressive symptoms. Likewise, more postpartum depressive symptoms were noted in women who presented an increase in apnea during the third trimester, an increase in nocturnal and early morning awakening as well as morning and daytime sleepiness throughout the pregnancy. These latest results are in agreement with those of Goyal et al. [32] in 124 primiparas followed up during the last month of pregnancy until three months postpartum but are in contradiction with those of Wolfson et al. [36] regarding the duration of sleep and early awakening. Finally, maternal snoring during the third trimester was confirmed as being associated with an increase in postpartum depressive symptoms, but contrary to O'Brien et al. [27] , we did not find that it was associated with an increase in diagnosed depression.
Nocturnal awakening in first trimester
More than a mere increase in depressive symptoms, certain sleep anomalies in pregnant women are significantly associated with lifelong diagnoses of depression according to DSM-IV criteria. This is the case for reduction of the duration of sleep and nocturnal awakening during the first trimester of pregnancy and for reduction of the duration of sleep during the second trimester. These results appear to suggest that a decrease in sleep duration at the beginning of pregnancy, a moment when the need for sleep increases, could underscore a vulnerability to depression or a sequela of a past depressive episode. In the same manner, the elevated frequency of nightmares and difficulties sleeping during pregnancy in the "depressed" group could be explained as the effects of a prior depressive episode [19] or as the prodomal state of postpartum depression (PPMD) [43] or an association of both. The pattern of sleep anomalies during pregnancy that we describe as being associated with a diagnosis of lifelong depression differs from that found by Coble et al. [26] in 14 women with a personal history of depression [26] . However, like this author, we are reporting sleep alterations that occurred very early in the pregnancies of these women at risk and in particular for the duration of sleep. Moreover, it should be noted that nocturnal awakening during the first trimester of pregnancy and early awakening, pain during sleep and morning sleepiness during the second trimester are linked to an increase in the probability of developing postpartum depression (PPMD) and not to the fact of having only one major depressive episode outside postpartum (MDOPP). These results suggest that the impact of a personal history of depression on the pregnant women's sleep is lower than a future episode of postpartum depression (PPMD).
The pattern of sleep that we have just described could therefore represent a prodromal state of PPMD or a marker for vulnerability to PPMD. Finally, the strong association that exists between PPMD and bipolarity could lead to the hypothesis that these sleep abnormalities during pregnancy could be interpreted more broadly as a risk factor for bipolarity in association with the circadian dysregulation that is described in this pathology [44, 45] . Knowledge of these abnormal sleep patterns should make it possible to better define strategies to improve sleep during pregnancy (bright light exposure, behavioral therapy for insomnia, manipulation of the sleep/wake rhythm, interpersonal and social rhythm therapy) in order to prevent PPMD [46, 47] .
The results of this study should be considered in the light of some limitations.
First of all, this study only used subjective sleep data within the limits of self-reporting, notably regarding sleep duration. Several authors have already reported that pregnant women sleep approximately 30 minutes less than they declare [28] .
Second, the retrospective collection of maternal sleep data during pregnancy may involve recall biases. This is however unlikely since sleep changes abnormalities reported in the current study are perfectly concordant with those described in previous studies conducted on similar populations [19, [23] [24] [25] 28, 32] .
Third, the women in our cohort had potentially few medical complications during pregnancy because our exclusion criteria were broad in terms of infant pathology and prematurity. It is therefore logical to hypothesize that these pregnant women could have better sleep than the general population. In this context, it is reassuring to observe for the generalization of our results, that the sleep disturbances during pregnancy that we have described are in agreement those described in other studies [23] [24] [25] .
Fourth, among the 217 women in our cohort, only 34 had a diagnosis of MDD according to DSM-IV criteria and only 17 of them developed PPMD. This low percentage of depression in our cohort is probably in part due to the selection bias induced by the long duration of the study (2 years). We could therefore hypothesize that given their symptoms, more depressed women refused to participate in the study or left before the end. While it is true that the low number of depressed women decreased the power of our results, the fact that the results related to the depressive symptoms of our entire cohort are in agreement with those of depressed women is in favor of their reliability. Of course, future studies with larger cohorts will be needed to confirm our results.
Fifth, some women who developed PPMD during follow-up had personal histories of depression before pregnancy. In that case, it is impossible to totally eliminate the impact of past depression on sleep pattern during pregnancy that is specifically associated with PPMD. However, the absence of an association between sleep anomalies during pregnancy and a major depressive episode outside of the postpartum period (MDOPP) supports the hypothesis of a PPMDspecific sleep pattern during pregnancy.
In conclusion, this study of 217 participants made it possible to describe the sleep patterns of women during pregnancy and confirmed certain anomalies found in previous studies. This is the first study that has attempted to characterize both sleep alterations in pregnant women with diagnosis of a lifelong major depressive episode and a sleep pattern that constitute a prodromal state or a vulnerability marker of PPMD. Our results could have a certain number of implications in terms of PPMD prevention in pregnant women and should enable the development of more specific strategies that aim to improve sleep to diminish PPMD. These results should be confirmed by longitudinal studies of large cohorts of women at great risk of MDD in order to better differentiate the sleep pattern of pregnant women presenting a history of depression from that of women who only have PPMD during the follow-up and who could therefore present a prodromal state or a risk factor for PPMD and perhaps even bipolarity.
